RADX Radiopharm Theranostics Ltd - ADR

$RADX , You left here (RADX) where you were posting about two or three extremely bullish messages three times a day. Suddenly, you left that office because I think you decided RADX had nothing good to offer shareholders. You went to CATX (which just collapsed by almost 50% in a few days), and I see that even there, despite the rout, you're still posting extremely bullish messages. I'm having a hard time understanding you... Will you switch to another stock when you decide $CATX has nothing good to offer shareholders? Where will you go next? Do you think many retail shareholders are being lulled into complacency by your messages? Seriously. Stop posting only to disappear a few days later when things don't go your way!

$RADX is pleased to announce it has received $8,000,000 from Rockford Capital under a funding facility secured against Radiopharm’s anticipated FY26 Research and Development Tax Incentive (RDTI). The funds will support the clinical trial pipeline and otherwise for general working capital of the Company. The funding agreement with Rockford Capital provides Radiopharm with early access to a portion of the Company’s anticipated FY26 RDTI. The facility is secured against the anticipated FY26 RDTI to be received from the Australian Taxation Office, with interest charged at a commercial rate. Repayment is timed to follow the anticipated receipt of the Company’s FY26 RDTI, and is due by 26 October 2027. The facility can be repaid at any time without penalty prior to this date. The Australian Government RDTI program provides companies engaging in eligible activities with a refundable tax offset of up to 43.5%.

$RADX even with the reverse split and a further CR, the stock has the potential to eventually trade around $7-$8. Still pretty good. Throw in the anticipated RAD101 partnership and things become even more interesting. Everyone is angry they won’t get to sell at $20/share like they wanted. They have destroyed the potential for it go above $10 but we can still break even and make money. Might just take few more months

$RADX , I partially agree, but a licensing agreement isn't "worthless": A licensing agreement for RAD101 is not a minor event. In the radiopharmaceutical industry, when a giant like Lantheus, Curium, or Siemens PETNET licenses a Phase 3 product, the agreement very often comes with an immediate upfront cash payment of several million or tens of millions of dollars. Furthermore, by transferring the cost of a 320-patient trial to a partner, Radiopharm eliminates the risk of having to raise a large, dilutive amount of capital. For a biotech company whose market capitalization has fallen below $15 million, securing such a partnership provides a crucial lifeline to secure its cash flow. We'll know for sure soon...

$RADX In addition to all this financial fiasco that's weighing us down, we can see that we're dealing with a bunch of amateurs... it's really going to be complicated to recover.

$RADX oral presentation at sno is great, hopefully they present the full dataset and have a partnership lined up. This will barcode for awhile

$RADX late breaking oral presentation at sno26 is a big deal. Hopefully they present specificity / sensitivity data for Rad101

$RADX it looks like today the price will fall below 1$ and soon a reverse split, most probably when we will recieve fda meeting minutes. Jesus what a monumental cluster fk.

$RADX now back up. As usual shaky investor. Bought some more, dont you see it's going according to plan? What happens in Axs is irrelevant. Worst stock owners ever.

$RADX This has been a highly coordinated takedown since end of July. You can see the channel clearly.

$RADX R&D Tax Incentive Received the 2025 financial year R&D tax refund of A$5,885,131 (including A$104,475 interest) in July 2026. Subsequent to 30 September 2026: Received A$8,000,000 from Rockford Capital under a funding facility secured against the anticipated FY26 Research and Development Tax Incentive (RDTI). Cash Position & Operating Cash Flow Closing cash: A$7.5 million at 30 September 2026 (up from A$4.1 million at the end of the prior quarter). Net cash outflows from operating activities: A$10.7 million. Direct R&D expenditure and staff costs accounted for 93% of operating expenditure for the quarter (excluding the R&D tax refund receipt). Other Subsequent to quarter-end, Radiopharm increased its ownership in Radiopharm Ventures from 87.5% to 93.75%. Payments to related parties (director fees) were made in the ordinary course of business at commercial rates.

$RADX that is pretty unbelieveable. whoever is responsible for this "mistake" should be fired.

$RADX Waiting for formal schedule 14A or Form 8-K to show up and sling shot to the moon! 🌕

$RADX “RAD101 represents a differentiated imaging approach targeting fatty acid synthase, a compelling biological mechanism that has demonstrated promising clinical potential in brain metastases,” continued Mr. Canevari. “As we prepare for pivotal development, we are also evaluating opportunities to engage with potential strategic partners who recognize the value of this program and share our vision for bringing this innovation to patients and clinicians worldwide. Given the scale of the opportunity and the maturity of the asset, we believe now is the appropriate time to explore pathways that could maximize both clinical impact and long-term value creation.”

$RADX I just don’t get why no one wants to buy this turd as a whole ? Preclinical companies with zero cash have been acquired in the past so why not this one ?

$RADX The investors presentation looks bad: 1. They need 320 patients for phase 3, that's a lot, if they are burning now 55mil per year, what amount will they burn then ? it could easily be over 100 mill. 2. Phase 2b is taking now 2 years for 30 patient and we still don't have full specificity and sensitivity. 320 patients will take easily 3-4 years and FDA approval another 1-2 year if everything is good. 3. They still don't have a partner, they expect soon letters of intention, wtf is that? Do they expect to finance the company with good will letters now? How much time it will take after they receive the letters to initiate a partnership another 2-3 months. 4. By the end of this month all the raised cash will be gone, if they will rise at this price levels, we will be diluted by another 50% just to finance the company for another 1-2 months. P.S. It looks very bad :(((

$RADX Fintel has two target prices as of 10-24-2026. That would be past dilution, but I can't verify it's accurate.

$RADX disclosed director interest changes and an unquoted securities notice in its 6-K filing.